Compare NRSN & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRSN | GOCO |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | Israel | United States |
| Employees | 15 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 24.5M |
| IPO Year | N/A | 2020 |
| Metric | NRSN | GOCO |
|---|---|---|
| Price | $0.78 | $1.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $8.50 | $4.75 |
| AVG Volume (30 Days) | ★ 187.1K | 106.7K |
| Earning Date | 03-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $361,845,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $90.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.22 |
| 52 Week High | $2.60 | $11.36 |
| Indicator | NRSN | GOCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 35.44 |
| Support Level | $0.66 | N/A |
| Resistance Level | $1.30 | $2.48 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 65.26 | 0.00 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.